The Medicare Part D drug benefit could save seniors more money than reimported medications, according to an AARP analysis using information from the Medicare Rx plan finder tool. However, AARP, which offers a Part D drug plan, indicated it still supports reimportation legislation as a benefit for non-Medicare patients. The Canadian mail-order provider ADVCare Pharmacy disputed the AARP report as circumstantial and misleading because it was compared with one or two Rx plans for only five patients.
Examining Barriers to Care in Diabetic Retinopathy Screening
November 30th 2023Prior research has shown the association between various socioeconomic variables and lower adherence to diabetic retinopathy screening, but few have elaborated on the patient perspective to understand the reason behind this association.